Telehealth Anxiety Prescribing: What Psychiatric NPs Can Do

You’ve spent years training to help patients manage anxiety disorders. You know the medications, understand the neuroscience, and can spot treatment-resistant cases from a mile away. But whether you’re a PMHNP wondering about your prescribing authority across state lines, or a psychiatrist considering how NP colleagues fit into your practice model, one question keeps coming up: Can psychiatric nurse practitioners actually prescribe anxiety medications — and if so, where and how?

The short answer: Yes, PMHNPs can prescribe anxiety medications, including controlled substances like benzodiazepines, in all 50 states. But the how varies dramatically depending on where you practice. In states like New York and Arizona, a PMHNP operates with the same prescriptive authority as a psychiatrist — no supervision needed. In Texas or Pennsylvania, that same PMHNP needs a formal physician collaboration agreement and faces additional restrictions on certain medications.

If you’re evaluating telehealth opportunities, planning to practice across state lines, or simply trying to understand what you can and can’t do with your current license, this matters. A lot.

Let’s cut through the regulatory fog and get to what actually affects your day-to-day practice treating anxiety patients.

Understanding PMHNP vs Psychiatrist Prescribing Authority: What’s Actually Different?

Here’s what most providers get wrong: they assume prescribing authority is binary — either you can prescribe or you can’t. The reality is far more nuanced, especially when it comes to psychiatric medications and controlled substances.

Psychiatrists (MD/DO) hold unrestricted prescribing authority in every state. Period. Whether you’re initiating an SSRI, adjusting benzodiazepine doses, or prescribing off-label medications for treatment-resistant anxiety, your scope is the same nationwide (assuming you’re licensed in that state). You answer to medical boards, DEA regulations, and standard of care — but not to collaborative practice requirements.

PMHNPs are a different story. Your prescribing authority depends entirely on your state’s nurse practice act and falls into one of three categories:

Full Practice Authority (FPA) States

In roughly half of U.S. states, PMHNPs can evaluate, diagnose, and prescribe medications — including Schedule IV anxiolytics like alprazolam and lorazepam — completely independently. No physician oversight. No collaborative agreements. No mandatory chart reviews.

Examples: New York (as of 2022), Oregon, Washington, Arizona, Colorado, Maryland.

In these states, a PMHNP managing anxiety operates with functionally identical authority to a psychiatrist. You can open your own practice, contract directly with insurance, and make all clinical decisions autonomously. The only real differences are your professional title and, in some cases, insurance reimbursement rates (more on that later).

Reduced Practice States

These states require PMHNPs to maintain a formal collaborative agreement with a physician to prescribe medications, but you retain significant autonomy in day-to-day practice. The physician doesn’t co-sign every prescription or see every patient, but they must be available for consultation and typically review a percentage of your charts periodically.

Examples: California (in transition), Illinois (with pathway to independence), Georgia, Oklahoma.

California’s Recent Shift: Thanks to AB 890, experienced California NPs can now achieve independent practice. As of January 2023, NPs with three years of experience can practice in certain group settings without standardized physician procedures (103 NP status). In 2026, those same NPs become eligible for full independent practice including solo telehealth (104 NP status). This is a seismic change for the most populous state in the country.

Illinois’ Hybrid Model: Illinois requires collaboration initially, but after 4,000 clinical hours and 250 hours of continuing education, PMHNPs can apply for Full Practice Authority. Even then, you need a one-time physician attestation to prescribe Schedule II controlled substances and benzodiazepines — essentially a sign-off that these medications are within your scope.

Restricted Practice States

These states require active physician supervision or delegation for all prescribing activities. The physician must be involved in treatment decisions, often co-signing prescriptions or maintaining close oversight of your patient panel.

Examples: Texas, Florida, Pennsylvania, North Carolina.

Texas is particularly restrictive: PMHNPs must have a Prescriptive Authority Agreement with a Texas physician for any prescribing. Beyond that, you face a hard prohibition on prescribing Schedule II controlled substances outside hospital or hospice settings. That means no outpatient Adderall scripts for comorbid ADHD, even if clinically indicated. Benzodiazepines (Schedule IV) are fair game if your delegating physician authorizes it, but the collaboration requirement never goes away.

Florida requires written protocols with a supervising physician. Interestingly, Florida carved out an exception for psychiatric NPs: while most Florida NPs can only prescribe a 7-day supply of controlled substances, psychiatric NPs treating mental health conditions are exempt from this limit. You can prescribe a full 30-day supply of Xanax for a patient with panic disorder — but you still need that supervisory relationship and protocol on file.

Pennsylvania mandates collaboration for your entire career unless laws change. Your supervising physician must review at least 10% of your charts, and 100% of any Schedule II prescriptions must be countersigned within 24 hours.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

The Federal Telehealth Prescribing Game-Changer You Need to Know About

Here’s where things get interesting for providers considering telehealth: federal rules trump state scope-of-practice laws when it comes to controlled substance prescribing via telemedicine.

Historically, the Ryan Haight Act required at least one in-person exam before prescribing controlled substances. This made remote psychiatric care — especially for anxiety patients needing benzodiazepines — nearly impossible.

COVID-19 changed everything.

Since March 2020, the DEA has allowed controlled substance prescribing via telehealth without any in-person visit. That flexibility was set to expire multiple times, creating a ‘telemedicine cliff’ that threatened to cut off millions of patients from care. In response, HHS and the DEA have extended these flexibilities through December 2026.

What this means for you:

• You can initiate benzodiazepines, stimulants, or other controlled medications via video visit
• No in-person exam required for the initial prescription or refills
• This applies to both psychiatrists and PMHNPs (within their state-authorized scope)
• Over 7 million controlled substance prescriptions were written via telehealth in 2024 alone under these rules

The catch? These are temporary flexibilities. The DEA is working on permanent regulations expected in late 2026. Those rules may require a special telemedicine registration or reinstate some exam requirements with modifications. For now, the door is wide open — but stay alert to regulatory changes if you’re building a telehealth-based practice.

State-Specific Telehealth Wrinkles

Most states align with federal policy, but a few add their own requirements:

Florida prohibits teleprescribing of Schedule II controlled substances — unless you’re treating a psychiatric disorder, managing inpatient/hospice care, or prescribing to nursing home residents. Since anxiety is a psychiatric disorder, you’re in the clear for remote prescribing of stimulants if treating comorbid ADHD. But if you’re an out-of-state provider with only Florida’s telehealth registration (not a full FL license), you cannot prescribe controlled substances remotely to Florida patients.

Texas bans telemedicine treatment of chronic pain with controlled drugs, but anxiety treatment is explicitly permitted. You must establish a valid patient-practitioner relationship via live audio-visual exam before prescribing anything.

California and New York impose no special telehealth prescribing restrictions beyond federal law. As long as you conduct an appropriate evaluation via video, you can prescribe controlled anxiety medications remotely.

The Real Economics: What PMHNPs and Psychiatrists Actually Get Paid

Let’s talk money, because scope of practice means nothing if you can’t sustain a viable practice.

Medicare Reimbursement: The Benchmark

Medicare sets rates that many private insurers follow. For 2026:

• 90792 (initial psychiatric evaluation with medication management): ~$202
• 99213 (15-minute medication follow-up): ~$95
• 99214 (25-minute moderate complexity visit): ~$136
• 90833 (30-minute therapy add-on): ~$81

These are solid rates compared to primary care. Medicare explicitly recognized mental health as an underfunded area and has maintained favorable psychiatric reimbursement to encourage provider participation.

The PMHNP Reimbursement Gap: Here’s the catch if you’re an NP — Medicare pays you at 85% of the physician fee schedule when you bill under your own NPI. That 99213 med check that pays a psychiatrist $95? You get about $81.

Some practices try to use ‘incident to’ billing (where the NP’s service is billed under the supervising physician’s NPI at 100%) to close this gap, but this rarely works in psychiatry. ‘Incident to’ requires the physician to be on-site, treating an established patient under an existing plan of care. Most psychiatric visits involve direct NP-patient interaction that doesn’t fit these narrow criteria, especially in telehealth.

The good news? Many states’ Medicaid programs and some private insurers pay NPs at the same rate as physicians. And since NP salaries are typically lower than psychiatrist salaries, the overall practice economics can still work in your favor — especially in high-volume telehealth settings.

Medicaid: Lower Rates, Higher Volume

Medicaid pays significantly less — often 40-60% of Medicare rates. That initial psychiatric evaluation might reimburse around $85 instead of $202. Follow-up visits can be as low as $40-50.

But here’s the trade-off: Medicaid volume is enormous. Patients with anxiety disorders, especially those with socioeconomic stressors, often qualify for Medicaid. In underserved areas, you can build a full patient panel quickly. Many telehealth platforms handle the billing complexity, allowing you to focus on clinical care while they manage prior authorizations and claims.

Private Insurance: The Variable Wild Card

Commercial rates typically run 100-150% of Medicare. A 99213 might pay $100-$140 depending on your contract. States with telehealth parity laws (California, New York, Illinois, Pennsylvania) require private insurers to reimburse virtual visits at the same rate as in-person, which levels the playing field for remote providers.

Some psychiatrists opt out of insurance entirely and charge cash rates ($150-$300 for initial visits, $100-$200 for follow-ups). This maximizes revenue per visit but requires excellent marketing to maintain patient flow — which brings us to an important point about practice economics.

The Patient Acquisition Cost Reality Nobody Talks About

Here’s what most solo or small-group providers don’t calculate when they’re comparing telehealth platforms to building their own practice: the true cost of acquiring a qualified psychiatric patient.

If you’re running independent marketing — SEO, Google Ads, directory listings — you’re not spending $30-50 per patient. That number is a fantasy. Here’s the reality:

Google Ads for mental health keywords run $15-40+ per click. Most clicks don’t convert to booked appointments. When you factor in testing different ad copy, optimizing landing pages, and managing campaigns (either your time or paying someone else), your cost per booked patient is typically $200-400+.

SEO takes 6-12 months of consistent investment before generating meaningful organic traffic. You’re paying for content creation, technical optimization, and backlink building with zero guaranteed results. Most solo providers don’t have the expertise or patience for this long game.

Directory listings like Psychology Today and Zocdoc charge monthly fees ($30-40/month for basic listings) and Zocdoc adds per-booking fees ($35-100+ depending on specialty and market). You’re also competing with hundreds of other providers on the same page. Total monthly cost when accounting for subscription + per-booking fees + opportunity cost of managing profiles easily exceeds $200/month before you see a single patient.

Add it all up — agency fees, failed campaigns, staff time qualifying leads, no-show rates from cold traffic — and you’re gambling $3,000-5,000/month on marketing with uncertain ROI.

This is where platforms like Klarity Health change the economics entirely.

Instead of paying upfront for marketing that might work, you pay a standard listing fee per new patient lead. The platform handles patient acquisition, matching, credentialing, telehealth infrastructure, and billing. You only pay when a qualified patient books with you.

Think of it this way: would you rather spend $4,000/month on marketing that might generate 10-15 new patients (if you’re lucky and know what you’re doing), or join a platform where you pay per appointment and can control your patient volume by adjusting your availability?

For most providers — especially those starting out, scaling up, or wanting predictable cash flow — the platform model removes all acquisition risk. You know your cost per patient, you control your schedule, and you can focus entirely on clinical care instead of becoming an amateur digital marketer.

State-by-State Breakdown: Where Can You Actually Prescribe Anxiety Meds?

Let’s get specific about the priority states where most telehealth opportunities exist:

California: The Transition State

Current Status: Historically restricted, now in transition to independence.

For Psychiatrists: Full independent authority. No restrictions on telehealth prescribing of any anxiety medication.

For PMHNPs:

• Before 2023: Required standardized physician protocols for all prescribing
• 2023-2025: Experienced NPs (3+ years) can practice in group settings without protocols (103 NP status)
• 2026 onward: Those same NPs eligible for full independent practice including solo telehealth (104 NP status)
• New graduates: Still require physician collaboration until they meet experience thresholds

Telehealth Specifics: No state-imposed controlled substance restrictions. AB 744 requires private insurance parity for telehealth. California is not in the Interstate Medical Licensure Compact (IMLC), so out-of-state psychiatrists need a full CA license to treat California patients.

Texas: The Restrictive Giant

Current Status: Restricted practice for NPs; independent for MDs.

For Psychiatrists: Full authority. Can prescribe all anxiety medications via telehealth if valid patient relationship established.

For PMHNPs:

• Mandatory Prescriptive Authority Agreement with Texas physician
• Cannot prescribe Schedule II controlled substances outside hospital/hospice settings (no outpatient stimulants for comorbid ADHD)
• Can prescribe benzodiazepines (Schedule IV) if authorized in delegation agreement
• Physician must be available for consultation; chart reviews required

Telehealth Specifics: Chronic pain treatment with controlled substances banned via telemedicine, but anxiety treatment permitted. No state payment parity law. Texas participates in IMLC for physician multi-state licensing. All controlled substance prescribers must check Texas PMP Aware database.

Workforce Context: Texas has one psychiatrist per ~8,966 residents — well above the concerning threshold. Telehealth could significantly expand access, but NP restrictions limit how effectively PMHNPs can fill gaps independently.

Florida: The Complicated Carve-Out

Current Status: Reduced practice for most NPs; full independence only for primary care NPs (excluding psychiatry).

For Psychiatrists: Full independent authority.

For PMHNPs:

• Written protocol with physician required for all practice and prescribing
• Can prescribe controlled substances if listed in protocol and you have DEA registration
• 7-day limit on Schedule II prescriptions — except psychiatric NPs treating mental health disorders are exempt (major carve-out)
• Can prescribe 30+ day supplies of benzodiazepines for anxiety disorders

Telehealth Specifics: Florida prohibits teleprescribing Schedule II controlled substances except for psychiatric treatment, inpatient, hospice, or nursing home care. Since anxiety is psychiatric, you can prescribe remotely. Out-of-state providers with only telehealth registration (not full FL license) cannot prescribe controlled substances to Florida patients remotely. E-FORCSE PDMP check mandatory.

New York: The Gold Standard

Current Status: Full Practice Authority for NPs as of 2022.

For Psychiatrists: Full independent authority.

For PMHNPs:

• No collaborative agreement required since 2022 Modernization Act
• Full prescriptive authority including controlled substances
• Can open independent practices, contract directly with payers
• Functionally equivalent to psychiatrist scope for anxiety treatment

Telehealth Specifics: Integrated into standard practice. No special controlled substance restrictions. Telehealth parity for insurance coverage. iSTOP PDMP check required for every controlled substance prescription (strictest in nation).

Workforce Context: New York has strong provider density (~1 psychiatrist per 2,913 residents), but upstate and rural areas still face shortages. FPA for NPs helps distribute care more effectively.

Pennsylvania: The Career-Long Collaboration State

Current Status: Restricted practice for NPs.

For Psychiatrists: Full independent authority.

For PMHNPs:

• Collaborative agreement required for entire career (no transition to independence)
• Physician must review at least 10% of charts
• 100% of Schedule II prescriptions must be countersigned within 24 hours
• Can prescribe benzodiazepines if authorized in collaboration agreement
• Physician can supervise maximum of 4 NPs

Telehealth Specifics: No comprehensive telehealth statute; providers follow federal guidelines and board recommendations. Many insurers voluntarily pay parity for tele-mental health. State Medicaid covers telehealth psychiatry fully.

Illinois: The Pathway State

Current Status: Reduced practice with pathway to independence.

For Psychiatrists: Full independent authority.

For PMHNPs:

• Initial collaboration required with physician
• After 4,000 hours + 250 CE hours: Can apply for Full Practice Authority
• Even with FPA: Need one-time physician attestation to prescribe Schedule II and benzodiazepines
• Once attestation obtained, can prescribe independently

Telehealth Specifics: Strong telehealth parity law (2021). Insurance must cover tele-mental health equivalently. Illinois PMP check required before initiating controlled substances and every 90 days thereafter.

Workforce Context: About 1 psychiatrist per 5,849 residents (below national average). Downstate Illinois faces significant shortages; telehealth expansion ongoing.

What This Means for Your Practice Decisions

If you’re a PMHNP:

• In FPA states (NY, AZ, etc.): You can build a completely independent telehealth practice managing anxiety. Your scope is effectively identical to a psychiatrist for routine cases.
• In reduced practice states (IL, CA post-2026): You can achieve independence with experience, but need to navigate transitional requirements and possibly maintain physician relationships for controlled substances.
• In restricted states (TX, FL, PA): You need a collaborative agreement before prescribing anything. Consider whether the physician supervision requirement is sustainable long-term, especially if doing pure telehealth across states.

If you’re a Psychiatrist:

• Your scope is unrestricted nationwide (within states where you’re licensed). The main considerations are licensing efficiency (IMLC states), telehealth payment parity, and patient volume opportunity.
• Understanding PMHNP scope helps if you’re supervising NPs or practicing in team settings — you’ll know what collaborative agreements actually require and whether they’re worth the administrative burden.

For both provider types:

• Telehealth platforms that handle credentialing, patient acquisition, and billing can remove the biggest barriers to practice — especially the marketing gamble and administrative overhead.
• States with provider shortages (TX, FL, PA, IL) offer the highest patient demand but may have more regulatory hurdles.
• Reimbursement differences between MDs and NPs (85% for Medicare) matter less when you control your volume and overhead is minimal.

Frequently Asked Questions

Can psychiatric nurse practitioners prescribe Xanax and other benzodiazepines?

Yes, in all 50 states — but the requirements vary. In Full Practice Authority states like New York, PMHNPs can prescribe benzodiazepines completely independently. In restricted states like Texas or Pennsylvania, you need a physician collaborative agreement that explicitly authorizes prescribing these Schedule IV controlled substances. You also need a DEA registration in addition to your state license.

What’s the difference between a PMHNP and a psychiatrist when it comes to prescribing anxiety medications?

Psychiatrists (MD/DO) can prescribe any anxiety medication independently in all states with no supervision requirements. PMHNPs have the same clinical training in psychiatric medication management, but legal authority varies by state. In about half of states, a PMHNP operates with functionally identical prescribing authority to a psychiatrist. In the other half, you need physician oversight ranging from consultation relationships to active supervision.

Can I prescribe anxiety medications via telehealth without seeing patients in person?

Yes, through December 2026 under extended federal flexibilities. You can initiate controlled substances including benzodiazepines via video visit without any in-person exam. This applies to both psychiatrists and PMHNPs (within their state-authorized scope). Some states add specific requirements — for example, Texas requires an audio-visual exam to establish the relationship, and Florida has carve-outs for psychiatric treatment. The DEA is working on permanent rules expected late 2026.

How does PMHNP reimbursement compare to psychiatrist reimbursement?

Medicare pays PMHNPs at 85% of the physician fee schedule when billing under your own NPI. For a typical 15-minute medication check (99213), a psychiatrist gets ~$95 while a PMHNP gets ~$81. Some Medicaid programs and private insurers pay equal rates. The gap matters less in high-volume practices or when platforms handle billing, since your primary concern is total monthly income, not per-visit rates.

Do I need a collaborative agreement to prescribe anxiety medications as a PMHNP in [specific state]?

• New York: No (full practice authority as of 2022)
• California: Depends — experienced NPs (103/104 status) no; new graduates yes
• Illinois: Initially yes, but can transition to independence after 4,000 hours + 250 CE hours (still need physician attestation for controlled substances)
• Texas: Yes, always (no pathway to independence)
• Florida: Yes (written protocol with physician required)
• Pennsylvania: Yes, for entire career (no independence pathway)

What’s the best state for PMHNPs to practice anxiety treatment via telehealth?

Full Practice Authority states offer the most autonomy: New York, Arizona, Oregon, Washington, Maryland, Colorado, New Mexico. These states allow you to operate completely independently without physician oversight, which is critical for pure telehealth models. California is becoming attractive as 104 NP status rolls out in 2026. Avoid Texas and Pennsylvania if you want long-term independent practice.

How much does it actually cost to market a psychiatric practice independently vs. joining a telehealth platform?

Independent marketing realistically costs $3,000-5,000/month when you account for Google Ads ($15-40+ per click with typical cost per booked patient of $200-400+), SEO (6-12 month investment before results), directory fees, and staff time qualifying leads. Failed campaigns and learning curves add to the cost. Platforms like Klarity use a pay-per-appointment model where you pay a listing fee only when a qualified patient books — eliminating upfront marketing spend and guaranteeing ROI.

The Bottom Line: Authority Matters, But Economics and Access Matter More

Yes, PMHNPs can prescribe anxiety medications including controlled substances. In half the country, you can do so with the same independence as a psychiatrist. In the other half, you’ll need physician collaboration — which may or may not be a barrier depending on your practice model and career goals.

But here’s what matters more than scope of practice: Can you actually build a sustainable practice treating the patients who need you most?

The traditional model — open an office, contract with insurers, figure out marketing, hire billing staff — requires massive upfront investment with uncertain returns. You might spend six months and $30,000 getting to a full patient panel. Or you might not.

Telehealth platforms built specifically for psychiatric prescribers flip that model. You bring your clinical expertise and prescribing authority. The platform handles patient acquisition, credentialing, technology infrastructure, billing, and compliance with state-specific regulations. You pay per appointment, not per click. You control your schedule, not your marketing budget.

For psychiatrists, this means accessing patient populations across multiple states without the overhead of traditional practice. For PMHNPs in Full Practice Authority states, it means building an independent practice without gambling on marketing. For PMHNPs in restricted states, it means platforms that have already secured the physician collaborations you need.

Ready to put your prescribing authority to work without the acquisition risk? Join Klarity’s provider network and start seeing qualified anxiety patients this month — in states where your license and scope allow you to practice at the top of your training.

Sources and Citations

The following sources were consulted to provide up-to-date regulatory and practice information (all verified as of February 26, 2026):

1. HHS Press Release – ‘HHS & DEA Extend Telemedicine Flexibilities through 2026’ (hhs.gov) – Official government source on federal telehealth prescribing policy (Published: January 2, 2026)

2. Florida Statutes §464.012 and §456.47 – Nurse Practice Act & Telehealth (flsenate.gov) – State law defining NP scope and telehealth rules in Florida (Effective: 2024-25)

3. California Board of Registered Nursing – AB 890 Implementation FAQs (rn.ca.gov) – State regulatory guidance on NP independent practice categories (Updated: 2024)

4. NPNY Announcement – ‘NP Modernization Act Passes in NY’ (npny.enpnetwork.com) – Documentation of New York’s full practice authority law (Published: April 9, 2022)

5. NursePractitionerLicense.com – Illinois NP Licensure & Limitations – Educational resource citing Illinois state law for NP practice authority (Updated: February 12, 2024)

6. Texas Medical Board FAQ – NP prescribing of Schedule II (tmb.state.tx.us) – Official state board guidance on physician delegation limits for controlled substances (Current law from 2019)

7. TheraThink – ‘Insurance Reimbursement Rates for Psychiatrists [2026]’ (therathink.com) – Analysis of CMS data for psychiatric billing rates (Published: 2025 for 2026 rates)

8. Healing Psychiatry Florida – ‘Psychiatrist Shortage by State – 2026 Report’ (healingpsychiatryflorida.com) – Compilation of HPSA and workforce data (Published: January 15, 2026)

9. Axios News – ‘COVID-era telehealth prescribing extended again’ (axios.com) – News reporting on DEA’s 2024 extension rule (Published: November 18, 2024)

10. Little Health Law Blog – ‘Texas Telemedicine Prescribing Rules’ (littlehealthlawblog.com) – Legal analysis of Texas regulations citing state statutes (Published: August 29, 2022)

Source:

• https://medx.it.com/yes-a-nurse-practitioner-can-prescribe-anxiety-meds-understanding-prescribing-authority#:~:text=Nurse%20practitioners%20,three%20categories%20of%20practice%20authority
• https://www.nursepractitionerlicense.com/nurse-practitioner-licensing-guides/limitations-of-practice-as-a-nurse-practitioner-in-illinois/#:~:text=Illinois%20is%20one%20of%20the,that%20they%20can%20handle%20unsupervised
• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20and,19%20pandemic%20and
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=2025
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=The%20telemedicine%20flexibilities%20were%20first,off%20access%20to%20needed%20medications
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=The%20extension%20gives%20DEA%20and,patient%20safety%20and%20preventing%20misuse
• https://www.flsenate.gov/laws/statutes/2022/456.47#:~:text=,is%20prescribed%20for%20the%20following
• https://www.littlehealthlawblog.com/texas-state-telemedicine-prescribing-rules/#:~:text=C
• https://medx.it.com/yes-a-nurse-practitioner-can-prescribe-anxiety-meds-understanding-prescribing-authority#:~:text=While%20any%20NP%20with%20prescriptive,Their%20expertise%20includes
• https://npny.enpnetwork.com/nurse-practitioner-news/216175-breaking-news-np-modernization-act-passes#:~:text=On%20April%209th%2C%20Governor%20Hochul,Practice%20Authority%20for%20NYS%20NPs